Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01941810 · ClinicalTrials.gov registry record · NA
Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
A NA study of Malignant Neoplasm and Cachexia, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 2
- Study locations
NCT01941810: Completed NA study of Malignant Neoplasm and Cachexia, sponsored by Wake Forest University Health Sciences.
NCT01941810 is a NA study of Malignant Neoplasm and Cachexia that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 14 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01941810, a NA study of Malignant Neoplasm and Cachexia, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot phase II trial studies how well bovine lactoferrin supplement works in improving taste in patients with cancer receiving chemotherapy. Bovine lactoferrin supplement may help improve the ability to taste food in patients who are receiving chemotherapy.
Primary Outcome
Tested separately by using paired t-tests to assess the significance of the baseline to one month changes.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- DIETARY_SUPPLEMENT bovine lactoferrin supplement
Study Locations (2)
North Carolina
- Comprehensive Cancer Center of Wake Forest University - Winston-Salem
Virginia
- Virginia Polytechnic Institute and State University - Blacksburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01941810 record still lists
NCT01941810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT01941810 reports a single indexed study location in North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT01941810 about?
NCT01941810 is a clinical study titled "Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy". This pilot phase II trial studies how well bovine lactoferrin supplement works in improving taste in patients with cancer receiving chemotherapy. Bovine lactoferrin supplement may help improve the ability to taste food in patients who are receiving chemotherapy.
What is the current status of trial NCT01941810?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2014-02. Estimated completion is 2015-10.
What conditions does trial NCT01941810 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Cachexia, Anorexia, Oral Complications of Chemotherapy.
What interventions are being tested in trial NCT01941810?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), bovine lactoferrin supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01941810?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01941810 being conducted?
This trial has 2 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01941810's enrollment target sits among peer trials
14 55th of 59 higher than 5 of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia